Nova Eye Medical Limited
ASX:EYE
$ 0.25
$-0.01 (-3.85%)
$ 0.25
$-0.01 (-3.85%)
End-of-day quote: 05/16/2024

Nova Eye Medical financials at a glance

The revenue of Nova Eye Medical is reported as 0.01703 billion Dollars in the fiscal year 2023. The earnings were 0 Dollars per share in 2023, which was 25 lower than 2019. And about -0.00708 billion Dollars are reported as free cash flow in the financials of Nova Eye Medical 2023. No dividends were paid to the shareholders of the Nova Eye Medical stock ASX:EYE in the financial year 2023.

$13.38M
Revenue
$-0.05
Earnings Per Share
82.89%
Gross Margin %
$-6.72M
Free Cash Flow
Revenue
13.38
Earnings Per Share
-0.05
Gross Margin %
82.89
Free Cash Flow
-6.72

Financials

Year Year TTM 2022 2019 2018 2017 2016 2015 2014 2013 2009 2007 2005
Rev. Revenue N/A $13.38M $81.64M $79.07M $71.64M $72.91M $62.68M $54.38M $42.81M $58.30M $44.40M $28.46M
GM % Gross Margin % 84.55% 82.89% 81.56% 58.42% 57.05% 57.43% 52.51% 50.84% 49.50% 49.94% 48.02% 51.25%
OM Operating Margin -69.19% -72.50% -43.66% -4.44% -0.11% 7.79% 4.32% 4.27% 0.07% 7.93% 6.53% 4.15%
EPS Earnings Per Share $-0.10 $-0.05 $-0.04 $-0.04 $0.01 $0.03 $0.02 $0.01 $-0.01 $0.04 $0.06 $-0.02
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 0 0 0 0.00% 0.00% 0.00% 0.00% -0.00% 0.00% 0 -0.00%
Sha. Shares N/AM 145.58M 143.6M 143.6M 121.15M 114.15M 107.65M 107.65M 84.91M 84.91M 68.4M 61.24M
OCF Operating Cash Flow N/A $-4.72M $-4.21M $0.52M $-3.50M $0.00M $0.00M $0.00M $0.00M $0.00M $0.00M $0.00M
FCF Free Cash Flow N/A $-6.72M $-4.93M $-2.12M $-14.04M $0.00M $0.00M $0.00M $0.00M $0.00M $0.00M $0.00M
FCFS Free Cash Flow Per Share $-0.05 $-0.07 $-0.05 $-0.04 $-0.12 $-0.03 $0.03 $-0.00 $-0.01 $0.01 $-0.00 $-0.06